Company / Assets per Share
Astria Therapeutics, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.10
FY2024
5-year range
$6.10 / $15.77
FY2020-FY2024
Trend
-27.9%
vs FY2023
Sector context
#136 of 210
Health Care
What the data says
At $6.10, Astria Therapeutics, Inc.'s assets per share ranks #136 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $2.48 in FY2016 to $15.77 in FY2022.
Based on SEC 10-K filings.
6.10 in FY2024 with a 5-year CAGR of +7.2%.
Declined from $15.77 to $6.10 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -24.7%
- 5-Year CAGR
- +7.2%
- 10-Year CAGR
- -
Sector benchmark
#136 of 210 in Health CareTop 65% of 210This company $6.10 Sector average $353.15
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2024, assets per share decreased 27.9% year-over-year.
- Ranks #136 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.10 | -27.9% |
| FY2023 | $8.45 | -46.4% |
| FY2022 | $15.77 | +10.4% |
| FY2021 | $14.29 | -7.9% |
| FY2020 | $15.52 | +259.7% |
| FY2019 | $4.31 | -44.3% |
| FY2018 | $7.75 | -6.1% |
| FY2017 | $8.25 | +233.2% |
| FY2016 | $2.48 | -69.0% |
| FY2015 | $7.98 | -78.8% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026